#Israel #Tel Aviv #Prodalim #Israel Corporation #TASE ILCO

Israel Corporation Reports Q1 2025 Results

Israel Corporation Ltd. (TASE: ILCO) announced its financial results for the first quarter of 2025, revealing both challenges and areas of solid performance. The company’s net profit for shareholders was reported at $35 million, a decrease from the $62 million recorded in the same period last year. This reflects ongoing strategic adjustments amid shifting market dynamics.

Financial Breakdown

Key Financial Figures

• - ILCO's share in ICL profit: $40 million (down from $48 million in Q1 2024)
• - ILCO share in Prodalim profit: $0 (no profit reported)
• - Amortization of excess cost in held companies: $(2) million (up from $(1) million in Q1 2024)
• - Financing income, general and other expenses at ILCO headquarters: $(5) million (an increase from $(1) million in the previous year)
• - Tax income: $2 million (down from $16 million)

Operating Liquidity

As of March 31, 2025, Israel Corporation's total financial liabilities stood at $723 million, balanced against investments in liquid assets amounting to $781 million, including $10 million in pledged deposits. The net cash available was reported at $21 million, influenced by the fair value of derivative transactions which added approximately $37 million to the financial liabilities. Notably, this figure was a significant drop from the $126 million reported as of December 31, 2025.

Strategic Developments

On March 5, 2025, ILCO finalized an investment agreement with Prodalim Investments Ltd., acquiring a 27.5% stake in the company. Prodalim focuses on innovative natural solutions across various industries, including beverage bases and flavor concentrates. They are currently pioneering advancements in the de-alcoholization sector, highlighting ILCO's commitment to high-growth areas.

Additionally, the Board of Directors declared a $15 million dividend in accordance with the company's policies, with a record date of April 9, 2025, and payment scheduled for April 21, 2025.

Future Outlook

ILCO’s financial outcomes are largely dependent on the performance of its invested entities. The company continues to monitor its portfolio, which includes significant holdings in ICL Group and AKVA Group, as it seeks to adjust its strategies in alignment with changing market conditions.

In 2019, ILCO outlined its strategy for expansion in sectors such as food technology, agriculture, healthcare, and industrial innovation. This commitment reflects a desire to leverage its operational and managerial expertise for heightened investment returns.

As a publicly traded entity on the Tel Aviv Stock Exchange and a member of the TA-35 Index, Israel Corporation is positioned to continue its role as a key player in the investment landscape. For detailed financial disclosures, stakeholders are encouraged to visit the company's filings on the Tel Aviv Stock Exchange's website.

For more insights into Israel Corporation and its strategic direction, check their official website at Israel Corporation.